Publications

Validating Self-Report and Proxy Reports of the Dexamethasone Symptom Questionnaire–Chronic for the Evaluation of Longer-Term Corticosteroid Toxicity

Meera Agar, Eng-Siew Koh, Emma Gibbs, Elizabeth H. Barnes, Elizabeth Hovey, Ann Livingstone, Kate Sawkins, Richard Chye, Melanie R. Lovell, Katherine Clark, Janette Vardy, Madeleine King, On behalf of the Cooperative Trials Group for Neuro-Oncology (COGNO).
Supportive Care in Cancer. Volume 24, pages 1209–1218, (2016).
Published online 21 August 2015.
.

QOLP-23. Phase II Randomised Placebo-Controlled Double-Blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent and/or Progressive High-Grade Glioma Requiring Treatment with Dexamethasone

Meera Agar, Anna Nowak, Elizabeth Hovey, Elizabeth Barnes, John Simes, Janette Vardy, Helen Wheeler, Robyn Leonard, Merryn Hall, Evonne Tim, Desma Spyridopoulos, Hao-Wen Sim, Zarnie Lwin, Anthony Dowling, Rosemary Harrup, Ross Jennens, Ganessan Kichenadasse, Tracey Dunlop, Cecelia Gzell, Eng-Siew Koh.
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii179–ii180, .
Society for Neuro-Oncology Annual Meeting, 2020 (poster abstract)

Phase II Randomized Placebo-Controlled Double-Blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent and/or Progressive High-Grade Glioma Requiring Treatment with Dexamethasone: The ACED Trial

Agar MR, Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler H, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z, Dowling A, Harrup RA, Jennens R, Kichenadasse G, Dunlop T, Gzell C, Koh ES.
Oceanic Palliative Care Conference. 2021 (poster abstract)

Acetazolamide Versus Placebo for Cerebral Oedema Requiring Dexamethasone in Recurrent and/or Progressive High-Grade Glioma: Phase II Randomised Placebo-Controlled Double-Blind Study

Agar MR, Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler HR, Kong BY, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z, Dowling A, Harrup R, Jennens R, Kichenadasse G, Dunlop T, Gzell C, Koh ES.
BMJ Support Palliat Care. 2023 Sep;13(3):354-362. . Epub 2023 Feb 17. PMID: 36807048.

Randomized Phase 2 Study of Carboplatin and Bevacizumab in Recurrent Glioblastoma

Kathryn M. Field, John Simes, Anna K. Nowak, Lawrence Cher, Helen Wheeler, Elizabeth J. Hovey, Christopher S.B. Brown, Elizabeth H. Barnes, Kate Sawkins, Ann Livingstone, Ron Freilich, Pramit M. Phal, Greg Fitt, CABARET/COGNO investigators and Mark A. Rosenthal.
Neuro-Oncology. 2015. Volume 17, Issue 11, Pages 1504–1513,
Published online 30 June 2015.

Early Perfusion MRI Predicts Survival Outcome in Patients with Recurrent Glioblastoma Treated with Bevacizumab and Carboplatin

Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP.
Journal of Neuro-Oncology. 2016. Volume 131, pages 321–329.
Published online 28 November 2016.

Health-Related Quality of Life Outcomes from CABARET: A Randomized Phase 2 Trial of Carboplatin and Bevacizumab in Recurrent Glioblastoma

Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak.
Journal of Neuro-Oncology. Volume 133, pages 623–631, (2017).
Published online 22 May 2017.

Continuing or Ceasing Bevacizumab Beyond Progression in Recurrent Glioblastoma: An Exploratory Randomized Phase II Trial

Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh, John Simes, on behalf of CABARET/COGNO investigators.
Neuro-Oncology Practice. Volume 4, Issue 3, September 2017, Pages 171–181.
Published online 25 May 2017.

The Role of Early MRI in Predicting Survival While on Bevacizumab in Recurrent Glioblastoma: Results from a Prospective Clinical Trial

Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H.
Cancer. 2017 Vol 123 (18) Pages 3576-3582.
Published online 5 June 2017.

Comparison Between Site and Central Radiological Assessments for Patients with Recurrent Glioblastoma on a Clinical Trial

Kathryn M. Field, Greg Fitt, Mark A. Rosenthal, John Simes, Anna K. Nowak, Elizabeth H. Barnes, Kate Sawkins, Christine Goh, Bradford A. Moffat, Simon Salinas, Lawrence Cher, Helen Wheeler, Elizabeth J. Hovey, Pramit M. Phal, CABARET/COGNO Investigators.
Asia-Pacific Journal of Clinical Oncology. Vol 14(5) October 2018 Pages e359-e365.
Published online 8 November 2017.